Clinical Trial Update: Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on optimizing comorbidity management in elderly patients with heart failure with preserved ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure Diastolic
• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Göteborg University | Conditions: Heart Failure, Diastolic | Phase 3 | Status: UNKNOWN